FourThought Financial’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$35K Buy
2,087
+914
+78% +$16.8K 0.01% 719
2022
Q2
$17K Buy
1,173
+200
+21% +$4.12K ﹤0.01% 901
2022
Q1
$24K Buy
973
+125
+15% +$3.23K ﹤0.01% 852
2021
Q4
$27K Sell
848
-124
-13% -$4.53K ﹤0.01% 850
2021
Q3
$34K Buy
972
+52
+6% +$2.05K ﹤0.01% 802
2021
Q2
$40K Buy
920
+195
+27% +$8.49K 0.01% 771
2021
Q1
$33K Sell
725
-21
-3% -$1.21K ﹤0.01% 792
2020
Q4
$51K Buy
+746
New +$36.5K 0.01% 658

Other funds holding LUNG

FourThought Financial's LUNG Position: Q3 2022 in Review

FourThought Financial increased its Pulmonx (LUNG) stake by 78% in Q3 2022, buying an estimated $16.8K and bringing the position to 2,087 shares worth $35K. The position accounts for 0.01% of the portfolio, ranked #719.

FourThought Financial first reported a position in LUNG in Q4 2020 and has held it in 8 quarters since. The position peaked at $51K in Q4 2020. 104 funds tracked by Wall St. Rank hold LUNG as of Q3 2022.

  • FourThought Financial held 2,087 shares of Pulmonx worth $35K as of Q3 2022.
  • FourThought Financial bought 914 Pulmonx shares in Q3 2022, an estimated $16.8K.
  • Pulmonx made up 0.01% of FourThought Financial's portfolio in Q3 2022, its #719 holding.
  • FourThought Financial first reported a position in Pulmonx in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's Pulmonx position peaked at $51K in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Pulmonx as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.